Company Financials

DexCom, Inc. Financials

United States dollar

business DexCom, Inc. Company Profile

Main Stock Listing

NASDAQ: DXCM

Market Capitalization $26.09 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 36.87
Forward PE 26.77
Price to Sales TTM $5.76
Price to Book MRQ $9.49
Enterprise to Revenue 5.57
Enterprise to EBITDA 24.60

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 15.96%
Operating Margin 20.05%
Return on Assets TTM 7.02%
Return on Equity TTM 30.64%

Income Statement

Revenue TTM $4,515,899,904
Revenue per Share TTM $11.54
Quarterly Revenue Growth 21.60%
Gross Profit TTM $2,664,999,936
EBITDA $1,222,400,000
Net Income to Common TTM $720,700,032
Diluted EPS TTM $1.80
Quarterly Earnings Growth YoY 110.80%

Balance Sheet

Total Cash MRQ $3,322,099,968
Total Cash per Share MRQ $8.52
Total Debt MRQ $
Total Debt to Equity MRQ 94.48
Current Ratio MRQ 1.57
Book Value per Share MRQ $6.99

Cash Flow

Operating Cash Flow TTM $1,448,099,968
Levered Free Cash Flow TTM $783,387,520

DXCM Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 390,000,000
Float Shares 387,418,764
Avg 10 Volume 3,595,520
Avg 30 Volume None
Shares Short 13,117,820
Short Ratio 2.41
Short % of Shares 4.32%
% Held by Insiders 0.42%
% Held by Institutions 99.68%

Stock Price Summary

Beta 1.52
Fifty Two Week Low $54.11
Fifty Two Week High $93.25
Fifty Two Week Change -20.05%
Day 50 MA $64.13
Day 200 MA $73.91

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2022-06-13